Resource

Unknown
Ask Source - Home. Brigton: Liquid Light Digital Ltd.; Unknown.
Bemnet A. The attitudes of Mutomo-Kitoo (Kitui-Kenya) people towards leprosy. Amsterdam: Royal Tropical Institute; Unknown.
The Care and Prevention of Injuries to Insensitive Feet. El Ciudado y Prevencion de Danos a Pies Insensitivos. Carville, Los Angeles: U.S.P.H.S. Hospital, Rehabilitation Research Department; Unknown.
Sudhindra CN. CBR Forum. Bangalore; Unknown.
Mediad. Chari-barometer. 1989 - ed. Rotterdam: Mediad Onderzoek & Advies BV; Unknown.
Anten R, Ottengraf P. An evaluation of nerve-release; objective and subjective results in operated leprosy-patiens. Amsterdam: NLR; Unknown.
Leiker DL. Leprosy in questions and answers. Kaduna: Northern Nigeria Ministry of Health Leprosy Service; Unknown.
Making it Work: Making human rights a reality for people with disabilities. s.l.; Unknown.
Rakotondranaivo A. Parler rapidiment en Malagasy: en 20 lecons [Speak quickly Malagasy: in 20 lessons]. s.l.: Trano printy loterana; Unknown.
Portal da Hanseniase. s.l.; Unknown.
Parke-Davis. Promin and Promizole in tuberculosis and leprosy. Michigan: Parke, Davis & Company; Unknown.
Stigma Research and Action. Amsterdam: VU University Amsterdam; Unknown.
Drijfhout M. Vaccinatie ter preventie van lepra. Amsterdam; Unknown.
Leiker DL. Van Mythe tot infectieziekte. Amsterdam: NLR; Unknown.
2012
Yang Q, Liu H, Low HQ, Wang H, Yu Y, Fu X, et al. Chromosome 2p14 is linked to susceptibility to leprosy. PLoS ONE. 2012;7(1):e29747. Abstract
Karthikeyan K, Latchoumibady K, Sowmya S. Double trouble: a case of von Recklinghausen's disease with coexistent lepromatous leprosy. J Infect Dev Ctries. 2012;6(3):287-9. Abstract
El-Khalawany M, Shaaban D, Sultan M, Abd Alsalam F. Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy. Clin Cosmet Investig Dermatol. 2012;5:1-6. Abstract
Sousa AL, Fava VM, Sampaio LH, Martelli CM, Costa MB, Mira MT, et al. Genetic and Immunological Evidence Implicates Interleukin 6 as a Susceptibility Gene for Leprosy Type 2 Reaction. J Infect Dis. 2012;205(9):1417-24. Abstract
Salgado CG, Ferreira DV, Frade MA, de Guimarães LS, Batista da Silva MB, Barreto JG. High Anti-Phenolic Glycolipid-I IgM Titers and Hidden Leprosy Cases, Amazon Region. Emerging Infect Dis. 2012;18(5):889-90. Abstract
Otsuka A, Ozaki M, Horiguchi Y, Murata Y, Kumano K, Nogami R, et al. Basophils Infiltrate the Skin Lesions in Lepromatous Leprosy. Acta Derm Venereol. 2012. Abstract
da Silva Rocha A, das Cunha MG, Diniz LM, Salgado C, Aires MA, Nery JA, et al. DRUG AND MULTIPLE-DRUG RESISTANCE AMONG MYCOBACTERIUM LEPRAE ISOLATES FROM BRAZILIAN RELAPSED LEPROSY PATIENTS. J Clin Microbiol. 2012. Abstract
Salgado CG, Barreto JG. Leonine facies: lepromatous leprosy. N Engl J Med. 2012;366(15):1433. Abstract
Michellin LB, Barreto JA, Marciano LH, Lara FA, Nogueira ME, Brito de Souza VN, et al. Leprosy patients: neurotrophic factors and axonal markers in skin lesions. Arq Neuropsiquiatr. 2012;70(4):281-6. Abstract
Geluk A, Bobosha K, van der Ploeg-van Schip JJ, Spencer JS, Banu S, Martins MV, et al. New Biomarkers with Relevance to Leprosy Diagnosis Applicable in Areas Hyperendemic for Leprosy. J Immunol. 2012. Abstract
John HV. Translating Leprosy: The Expert and the Public in Stanley Stein's Anti-stigmatization Campaigns, 1931–60. J Hist Med Allied Sci. 2012. Abstract